Azaindoles useful as inhibitors of Janus kinases
US8163917B2 · kind B2 · utility
23Cited by
4References
58Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 7, 2010 |
| Grant date | Apr 24, 2012 |
| Priority date | — |
| Expiry date | May 7, 2030 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Y207/10002
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to compounds useful as inhibitors of protein kinases, particularly of JAK family kinases. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compositions in the treatment of various disease, conditions, or disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.